Investigating the biomarker potential of glycoproteins using comparative glycoprofiling - application to tissue inhibitor of metalloproteinases-1

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1784, Issue 3, 2008, Pages 455-463

  Thaysen Andersen, Morten ^a   Thøgersen, Ida B ^b   Lademann, Ulrik ^c   Offenberg, Hanne ^c   Giessing, Anders M B ^a   Enghild, Jan J ^b   Nielsen, Hans Jørgen ^d   Brünner, Nils ^c   Højrup, Peter ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Biomarker; Colorectal cancer; Glycoprofiling; Mass spectrometry; TIMP 1

Indexed keywords

GLYCOPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANTIBODY AFFINITY; ARTICLE; CANCER CELL CULTURE; CELL LINE; COLORECTAL CANCER; DISEASE MARKER; EARLY DIAGNOSIS; GEL ELECTROPHORESIS; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN GLYCOSYLATION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY;

AGED; CARBOHYDRATE SEQUENCE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR MARKERS, BIOLOGICAL;

EID: 43049129188     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2007.12.007     Document Type: Article

References (31)

1. Chatterjee S.K., and Zetter B.R. Cancer biomarkers: knowing the present and predicting the future. Future Oncol. 1 (2005) 37-50
2. Hudson M.A., Bahnson R.R., and Catalona W.J. Clinical use of prostate specific antigen in patients with prostate cancer. J. Urol. 142 (1989) 1011-1017
3. Meezan E., Wu H.C., Black P.H., and Robbins P.W. Comparative studies on carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. separation of glycoproteins and glycopeptides by sephadex chromatography. Biochemistry 8 (1969) 2518-2524
4. Fukuda M. Cell surface glycoconjugates as onco-differentiation markers in hematopoietic cells. Biochim. Biophys. Acta 780 (1985) 119-150
5. Turner G.A. N-glycosylation of serum-proteins in disease and its investigation using lectins. Clin. Chim. Acta 208 (1992) 149-171
6. Saussez S., Marchant H., Nagy N., Decaestecker C., Hassid S., Jortay A., Schuring M.P., Gabius H.J., Danguy A., Salmon I., and Kiss R. Quantitative glycohistochemistry defines new prognostic markers for cancers of the oral cavity. Cancer 82 (1998) 252-260
7. Dennis J.W., Laferte S., Waghorne C., Breitman M.L., and Kerbel R.S. Beta-1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236 (1987) 582-585
8. Seales E.C., Jurado G.A., Brunson B.A., Wakefield J.K., Frost A.R., and Bellis S.L. Hypersialylation of the beta 1 integrins, observed in the colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res. 65 (2005) 4645-4652
9. Block T.M., Comunale M.A., Lowman M., Steel L.F., Romano P.R., Fimmel C., Tennant B.C., London W.T., Evans A.A., Blumberg B.S., Dwek R.A., Mattu T.S., and Mehta A.S. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 779-784
10. Kossowska B., Ferens-Sieczkowska M., Gancarz R., Passowicz-Muszynska E., and Jankowska R. Fucosylation of serum glycoproteins in lung cancer patients. Clin. Chem. Lab. Med. 43 (2005) 361-369
11. Dabelsteen E. Cell surface carbohydrates as prognostic markers in human carcinomas. J. Pathol. 179 (1996) 358-369
12. Xu Z., Zhou X., Lu H., Wu N., Zhao H., Zhang L., Zhang W., Liang Y.L., Wang L., Liu Y., Yang P., and Zha X. Comparative glycoproteomics based on lectins affinity capture of N-linked glycoproteins from human Chang liver cells and MHCC97-H cells. Proteomics 7 (2007) 2358-2370
13. Hägglund P., Matthiesen R., Elortza F., Højrup P., Roepstorff P., Jensen O.N., and Bunkenborg J. An enzymatic deglycosylation scheme enabling identification of core fucosylated N-glycans and O-glycosylation site mapping of human plasma proteins. J. Proteome Res. 6 (2007) 3021-3031
14. Hägglund P., Bunkenborg J., Elortza F., Jensen O.N., and Roepstorff P. A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J. Proteome Res. 3 (2004) 556-566
15. Thaysen-Andersen M., Thøgersen I.B., Nielsen H.J., Lademann U., Brünner N., Enghild J., and Højrup P. Rapid and individual-specific glycoprofiling of the low abundance N-glycosylated protein tissue inhibitor of metalloproteinases-1. Mol. Cell. Proteomics 6 (2007) 638-647
16. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., and Engler J.A. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4 (1993) 197-250
17. Luparello C., Avanzato G., Carella C., and Pucci-Minafra I. Tissue inhibitor of metalloproteinases (TIMP-1) and proliferative behaviour of clonal breast cancer cells. Breast Cancer Res. Treat. 54 (1999) 235-244
18. Guedez L., Stetler-Stevenson W.G., Wolff L., Wang J., Fukushima P., Mansoor A., and Stetler-Stevenson M. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J. Clin. Invest. 102 (1998) 2002-2010
19. Li G., Fridman R., and Kim H.R. Tissue inhibitor of metalloproteinases-1 inhibits apoptosis of human breast epithelial cells. Cancer Res. 59 (1999) 6267-6275
20. Jung K., Nowak L., Lein M., Henke W., Schnorr D., and Loening S.A. What kind of specimen should be selected for determining tissue inhibitor of metalloproteinase-1 (TIMP-1) in blood?. Clin. Chim. Acta 254 (1996) 97-100
21. Simpson R.A., Hemingway D.M., and Thompson M.M. Plasma TIMP-1 - a marker of metastasis in colorectal cancer. Colorectal Dis. 2 (2000) 100-105
22. Holten-Andersen M.N., Christensen I.J., Nilbert M., Bendahl P.O., Nielsen H.J., Brünner N., and Fernebro E. Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival: a validation study. Eur. J. Cancer 40 (2004) 64-72
23. Holten-Andersen M.N., Christensen I.J., Nielsen H.J., Stephens R.W., Jensen V., Nielsen O.H., Sørensen S., Overgaard J., Lilja H., Harris A., Murphy G., and Brünner N. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. Clin. Cancer Res. 8 (2002) 156-164
24. Holten-Andersen M.N., Murphy G., Nielsen H.J., Pedersen A.N., Christensen I.J., Høyer-Hansen G., Brünner N., and Stephens R.W. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br. J. Cancer 80 (1999) 495-503
25. Møller Sørensen N., Dowell B.L., Stewart K.D., Jensen V., Larsen L., Lademann U., Murphy G., Nielsen H.J., Brünner N., and Davis G.J. Establishment and characterization of 7 new monoclonal antibodies to tissue inhibitor of metalloproteinases-1. Tumour Biol. 26 (2005) 71-80
26. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels. Anal. Chem. 68 (1996) 850-858
27. Gobom J., Nordhoff E., Mirgorodskaya E., Ekman R., and Roepstorff P. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom. 34 (1999) 105-116
28. Linden J.C., and Lawhead C.L. Liquid chromatography of saccharides. J. Chromatogr. 105 (1975) 125-133
29. Kim Y., Hwang S.Y., Kang H., Sohn H., Oh S., Kim J., Yoo J.S., Kim Y.H., Kim C., Jeon J., Lee J.M., Kang H.A., Miyoshi E., Taniguchi N., Yoo H., and Ko J. Functional proteomics study reveals that N-acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on TIMP-1. Mol. Cell. Proteomics 7 (2008) 1-14
30. Mortz E., Sareneva T., Julkunen I., and Roepstorff P. Does matrix-assisted laser desorption ionization mass spectrometry allow analysis of carbohydrate heterogeneity in glycoproteins? A study of natural human interferon-gamma. J. Mass Spectrom. 31 (1996) 1109-1118
31. Holten-Andersen M.N., Hansen U., Brünner N., Nielsen H.J., Illemann M., and Nielsen B.S. Localization of Tissue Inhibitor of Metalloproteinases 1 (TIMP-1) in human colorectal adenomas and adenocarcinomas. Int. J. Cancer 113 (2005) 198-206